They basically said the market had got it wrong and not realised that it had income and expenses that where skewed which made the first half look better and the second half look poorer. eg cash flow...
Large contracts towards the end of the financial year meant there was a working capital drag of approximately $2.45 million. There was also $0.7 million of goods that were pre-ordered for work that will be completed in FY15.
Eureka puts a 46c valuation on it
- Forums
- ASX - By Stock
- AZV
- Ann: 2014 Results announcement
Ann: 2014 Results announcement, page-18
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AZV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online